Artivion | CRY - Sales Revenues

Stock Price
38.33
Daily Change
0.33 0.87%
Monthly
-13.50%
Yearly
35.63%
Q1 Forecast
37.14

Artivion reported $95.78M in Sales Revenues for its fiscal quarter ending in September of 2024.





Sales Change Date
Abbott USD 11.46B 90M Dec/2025
Accuray USD 116.17M 14.63M Dec/2024
AngioDynamics USD 72M 841K Feb/2025
Artivion USD 95.78M 2.24M Sep/2024
AtriCure USD 140.5M 6.2M Dec/2025
Baxter International USD 2.97B 130M Dec/2025
Becton, Dickinson and Co. USD 5.3B 600M Dec/2025
Boston Scientific USD 5.29B 220M Dec/2025
Edwards Lifesciences USD 1.57B 20M Dec/2025
Inogen USD 74.93M 504K Sep/2024
Integra LifeSciences USD 402.06M 13.54M Sep/2025
J&J USD 24.6B 610M Dec/2025
Mesa Laboratories USD 62.84M 5.01M Dec/2024
Orthofix International USD 799.49M 602.88M Dec/2024
Pfizer USD 17.58B 880M Dec/2025
ResMed USD 1.4B 100M Dec/2025
Stryker USD 7.2B 1.14B Dec/2025
Surmodics USD 29.92M 96.16M Dec/2024
Tandem Diabetes Care USD 290.4M 41.15M Dec/2025
Teleflex USD 913M 132.11M Sep/2025
Terumo JPY 296.63B 21.66B Dec/2025
Trinity Biotech USD 14.31M 1.55M Sep/2025